Closed for Enrollment

• A Pilot Investigation of Blood-derived Circulating Tumor DNA (ctDNA), Circulating Tumor RNA (ctRNA) and Circulating Tumor miRNA in Pancreatic Cancer Patients Jacksonville, Fla.

  The purpose of this study is to establish a cohort of 200 patients receiving definitive radiotherapy at Mayo Clinic Florida for locally advanced pancreatic cancer (T3-4NxM0; TxN+M0), and establish a biobank of 10 ml of plasma (frozen at –80o C) for each patient at baseline (prior to starting radiation treatment), week 2 of radiation treatment and 4-8 weeks following radiation treatment.